Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recs

0
Player Avatar pchop123 (76.62) Submitted: 8/7/2012 4:34:03 PM : Underperform Start Price: $3.95 CADX Score: +0.13

expenses keep exceeding revenues & that will not get any better with all their current marketing expenses

Featured Broker Partners


Advertisement